EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae

Mahmoud Saad Abdel-Halim iD, Amira M El-Ganiny, Basem Mansour, Galal Yahya, Hemat K Abd El Latif, Momen Askoura

BMC Microbiology · 27.02.2024 · 24 (1)

DOI: 10.1186/s12866-024-03214-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Microbiology, online erschienen am 27.02.2024. Verfasst von Mahmoud Saad Abdel-Halim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Immunology Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt. mahmoudsaad@zu.edu.eg. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zagazig University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Carbapenems represent the first line treatment of serious infections caused by drug-resistant Klebsiella pneumoniae . Carbapenem-resistant K. pneumoniae (CRKP) is one of the urgent threats to human health worldwide. The current study aims to evaluate the carbapenemase inhibitory potential of coumarin and to test its ability to restore meropenem activity against CRKP. Disk diffusion method was used to test the antimicrobial susceptibility of K. pneumoniae clinical isolates to various antibiotics. Carbapenemase genes (NDM-1, VIM-2, and OXA-9) were detected using PCR. The effect of sub-MIC of coumarin on CRKP isolates was performed using combined disk assay, enzyme inhibition assay, and checkerboard assay. In addition, qRT-PCR was used to estimate the coumarin effect on expression of carbapenemase genes. Molecular docking was used to confirm the interaction between coumarin and binding sites within three carbapenemases.

Results

K. pneumoniae clinical isolates were found to be multi-drug resistant and showed high resistance to meropenem. All bacterial isolates harbor at least one carbapenemase-encoding gene. Coumarin significantly inhibited carbapenemases in the crude periplasmic extract of CRKP. The checkerboard assay indicated that coumarin-meropenem combination was synergistic exhibiting a fractional inhibitory concentration index ≤ 0.5. In addition, qRT-PCR results revealed that coumarin significantly decreased carbapenemase-genes expression. Molecular docking revealed that the binding energies of coumarin to NDM1, VIM-2, OXA-48 and OXA-9 showed a free binding energy of -7.8757, -7.1532, -6.2064 and − 7.4331 Kcal/mol, respectively.

Conclusion

Coumarin rendered CRKP sensitive to meropenem as evidenced by its inhibitory action on hydrolytic activity and expression of carbapenemases. The current findings suggest that coumarin could be a possible solution to overcome carbapenems resistance in CRKP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeKlebsiella InfectionsHumansMeropenemMolecular Docking SimulationBacterial ProteinsAnti-Bacterial Agentsbeta-LactamasesCarbapenemsCoumarinsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Klebsiella pneumoniaeCarbapenem-resistantCheckerboard assayCoumarinMolecular dockingqRT-PCR

Substanzen

carbapenemaseMeropenemBacterial ProteinsAnti-Bacterial Agentsbeta-LactamasesCarbapenemsCoumarins

Autor:innen und Institutionen

  • Microbiology and Immunology Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt. mahmoudsaad@zu.edu.eg.
  • Microbiology and Immunology Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.
  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt.

ORCID-Profile: Mahmoud Saad Abdel-Halim

Förderung

  • Zagazig University

Zitieren

APA

Abdel-Halim, M. S., El-Ganiny, A. M., Mansour, B., Yahya, G., Latif, H. K. A. E., & Askoura, M. (2024). Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae. BMC Microbiology, 24(1). https://doi.org/10.1186/s12866-024-03214-7

Vancouver

Abdel-Halim MS, El-Ganiny AM, Mansour B, Yahya G, Latif HKAE, Askoura M. Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae. BMC Microbiology. 2024;24(1). doi:10.1186/s12866-024-03214-7

BibTeX
@article{AbdelHalim2024,
  author = {Abdel-Halim, Mahmoud Saad and El-Ganiny, Amira M and Mansour, Basem and Yahya, Galal and Latif, Hemat K Abd El and Askoura, Momen},
  title = {Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae},
  journal = {BMC Microbiology},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1186/s12866-024-03214-7}
}
Kostenlos starten →